{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:36:58Z","timestamp":1778755018302,"version":"3.51.4"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,1,31]]},"DOI":"10.18632\/aging.102716","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T23:20:17Z","timestamp":1581031217000},"page":"1843-1856","source":"Crossref","is-referenced-by-count":60,"title":["Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101\/EZH2 axis as a ceRNA"],"prefix":"10.18632","volume":"12","author":[{"given":"Bai-Quan","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia-Hui","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Dong","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Qiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Jun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Lu","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Mei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Fei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"},{"name":"Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Bing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/SLA.0000000000002670","article-title":"Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes.","volume":"26","author":"Lin","year":"2019","journal-title":"Ann Surg"},{"key":"3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1236-z","article-title":"Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma.","volume":"1","author":"Guo","year":"2018","journal-title":"Cell Death Dis"},{"key":"4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13046-018-0966-1","article-title":"Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).","volume":"3","author":"Ye","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"5","doi-asserted-by":"publisher","first-page":"14519","DOI":"10.1002\/jcp.28143","article-title":"SNHG20: A vital lncRNA in multiple human cancers.","volume":"23","author":"Wu","year":"2019","journal-title":"J Cell Physiol"},{"key":"6","doi-asserted-by":"publisher","first-page":"10157","DOI":"10.1002\/jcp.27684","article-title":"The lncRNA SCARNA2 mediates colorectal cancer chemoresistance through a conserved microRNA-342-3p target sequence.","volume":"23","author":"Zhang","year":"2019","journal-title":"J Cell Physiol"},{"key":"7","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/jcp.27095","article-title":"LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128\/CD151 pathway in hepatocellular carcinoma.","volume":"23","author":"Ke","year":"2019","journal-title":"J Cell Physiol"},{"key":"8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13046-018-0845-9","article-title":"Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.","volume":"3","author":"Li","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-18-2363","article-title":"Exosome-TransmittedandPromote Proteasome Inhibitor Resistance in Multiple Myeloma.","volume":"2","author":"Zhuang","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13046-018-0724-4","article-title":"LncRNA-TUSC7\/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.","volume":"3","author":"Qin","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1158\/1078-0432.CCR-17-1851","article-title":"Functional Role of a Novel Long Noncoding RNAin Esophageal Squamous Cell Carcinoma Progression and Metastasis.","volume":"2","author":"Xu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41419-018-0454-8","article-title":"CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7.","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis"},{"key":"13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.7150\/jca.11735","article-title":"Argonaute 2: A Novel Rising Star in Cancer Research.","volume":"6","author":"Qian","year":"2015","journal-title":"J Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00018-018-2946-1","article-title":"Long non-coding RNAs involved in cancer metabolic reprogramming.","volume":"7","author":"Li","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"15","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41418-018-0084-9","article-title":"LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.","volume":"2","author":"Bai","year":"2018","journal-title":"Cell Death Differ"},{"key":"16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2017.12.016","article-title":"The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma.","volume":"41","author":"Lee","year":"2018","journal-title":"Cancer Lett"},{"key":"17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.bbrc.2017.11.119","article-title":"Negative regulation of lncRNA GAS5 by miR-196a inhibits esophageal squamous cell carcinoma growth.","volume":"49","author":"Bai","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"18","first-page":"3310","article-title":"MiR-101: a potential therapeutic target of cancers.","volume":"1","author":"Tang","year":"2018","journal-title":"Am J Transl Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1158\/0008-5472.CAN-08-3114","article-title":"The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.","volume":"6","author":"Jones","year":"2009","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/JTO.0b013e318208eb35","article-title":"MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.","volume":"6","author":"Wang","year":"2011","journal-title":"J Thorac Oncol"},{"key":"21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13148-015-0107-z","article-title":"MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.","volume":"7","author":"Rota","year":"2015","journal-title":"Clin Epigenetics"},{"key":"22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jhep.2013.10.028","article-title":"MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.","volume":"6","author":"Cicinnati","year":"2014","journal-title":"J Hepatol"},{"key":"23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3892\/etm.2011.284","article-title":"microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2.","volume":"2","author":"Son","year":"2011","journal-title":"Exp Ther Med"},{"key":"24","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.3892\/or.2014.3459","article-title":"MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression.","volume":"3","author":"Ma","year":"2014","journal-title":"Oncol Rep"},{"key":"25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing.","volume":"29","author":"Zhang","year":"2002","journal-title":"Science"},{"key":"26","doi-asserted-by":"publisher","first-page":"9911","DOI":"10.1074\/jbc.RA119.008152","article-title":"Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer.","volume":"29","author":"Liu","year":"2019","journal-title":"J Biol Chem"},{"key":"27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12943-017-0715-7","article-title":"Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.","volume":"1","author":"Bai","year":"2017","journal-title":"Mol Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"E3509","DOI":"10.1073\/pnas.1802691115","article-title":"Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells.","volume":"11","author":"Wajapeyee","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3779\/j.issn.1009-3419.2019.05.01","article-title":"[Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells].","volume":"2","author":"Chen","year":"2019","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13578-018-0260-0","article-title":"TUG1 confers cisplatin resistance in esophageal squamous cell carcinoma by epigenetically suppressing PDCD4 expression via EZH2.","volume":"8","author":"Liu","year":"2018","journal-title":"Cell Biosci"},{"key":"31","doi-asserted-by":"publisher","first-page":"25668","DOI":"10.18632\/oncotarget.8257","article-title":"Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting \u03b2-catenin via Ezh2.","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/1354750X.2015.1118537","article-title":"Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.","volume":"2","author":"Sang","year":"2016","journal-title":"Biomarkers"},{"key":"33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.prp.2012.05.012","article-title":"Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma.","volume":"20","author":"Kim","year":"2012","journal-title":"Pathol Res Pract"},{"key":"34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ijc.25031","article-title":"High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.","volume":"12","author":"Xie","year":"2010","journal-title":"Int J Cancer"},{"key":"35","doi-asserted-by":"publisher","first-page":"e2201","DOI":"10.1038\/cddis.2015.324","article-title":"Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling.","volume":"7","author":"Shi","year":"2016","journal-title":"Cell Death Dis"},{"key":"36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.omtn.2018.12.006","article-title":"Long Non-coding RNA PVT1 Competitively Binds MicroRNA-424-5p to Regulate CARM1 in Radiosensitivity of Non-Small-Cell Lung Cancer.","volume":"1","author":"Hu","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-019-0957-7","article-title":"A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p\/FOXA1 axis.","volume":"1","author":"Tu","year":"2019","journal-title":"Mol Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-017-0702-z","article-title":"Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2\/miR-367\/FBXW7 axis.","volume":"1","author":"Tu","year":"2017","journal-title":"Mol Cancer"},{"key":"39","doi-asserted-by":"publisher","first-page":"11256","DOI":"10.1002\/jcp.27783","article-title":"CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT\/ERK1\/2 signaling.","volume":"23","author":"Wu","year":"2019","journal-title":"J Cell Physiol"},{"key":"40","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/cam4.1313","article-title":"Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling.","volume":"7","author":"Xu","year":"2018","journal-title":"Cancer Med"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:00:59Z","timestamp":1599076859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,31]]}},"alternative-id":["102716","32005028"],"URL":"https:\/\/doi.org\/10.18632\/aging.102716","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]}}}